Sign up to save your podcasts
Or
Share ARCHWAY at AAO
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ARCHWAY at AAO
The Port Delivery System With Ranibizumab (Genentech) is under investigation for the treatment of wet AMD in the phase 3 ARCHWAY trial, data from which was shared at this year’s AAO Annual Meeting. Nancy Holekamp, MD, sits down with NRR to provide a primary analysis of the results of ARCHWAY and discusses safety outcomes.
This editorially independent podcast is supported with advertising.
View all episodes
By Retina Today
4.4
1717 ratings
The Port Delivery System With Ranibizumab (Genentech) is under investigation for the treatment of wet AMD in the phase 3 ARCHWAY trial, data from which was shared at this year’s AAO Annual Meeting. Nancy Holekamp, MD, sits down with NRR to provide a primary analysis of the results of ARCHWAY and discusses safety outcomes.
This editorially independent podcast is supported with advertising.
More shows like New Retina Radio by Eyetube
View all
Ophthalmology off the Grid by Eyetube
43 Listeners
White Coat Investor Podcast
2,435 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
Interesting Times with Ross Douthat
7,062 Listeners
American Journal of Ophthalmology Podcasts Collection
11 Listeners
Headlight in the fog: The Uveitis Podcast
21 Listeners
Experts InSight
52 Listeners
RETINA Journal Podcasts
10 Listeners
Ophthalmology Journal
18 Listeners
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
0 Listeners
Talking Euretina
1 Listeners
Mayo Clinic Ophthalmology Podcast
19 Listeners
ASRS's History of Retina
0 Listeners
Your Money Guide on the Side
1,270 Listeners
RetinaRounds™
0 Listeners